Results From Drug Trials and New Risk Factors Announced at International Alzheimer's Conference Jul 15, 2009
A six month study was conducted by Martek Biosciences Corporation in healthy older people to see DHA's effect on "age related cognitive decline." This trial showed a positive result on one test of memory and learning. The results need confirmation. (PR Newswire)
Results from trials of DHA in Alzheimer's disease and age-related cognitive decline Jul 12, 2009
One of the trials was conducted by the Alzheimer's Disease Cooperative Study (ADCS) supported by the National Institute on Aging (NIA), and the second by Martek Biosciences Corporation (Martek), the primary company that makes algal DHA for supplementation ... Researchers at Martek Biosciences Corporation examined the effects of algal DHA as a possible neuroprotective nutritional supplement for ARCD in their Memory Improvement with DHA Study (MIDAS) ... (Funders: National Institute on Aging;... (EurekAlert!)
Martek to Host Investor Conference Call to Discuss Research Presented at the International Conference on Alzheimer's Disease in Vienna, Austria Jul 11, 2009
July 10 /PRNewswire-FirstCall/ -- Martek Biosciences Corporation (Nasdaq: ) announced today that it will conduct a conference call for investors to discuss DHA research recently presented at the International Conference on Alzheimer's Disease ... Martek Biosciences Corporation is a leader in the innovation and development of DHA omega-3 products that promote health and wellness through every stage of life ... SOURCE Martek Biosciences Corporation. (PR Newswire)
